Address

Qantev SAS
Paris
France

Open Map


VCID: 17604804
http://vcinvest.com/node/17604804
    Profile

    Corporate information

    Official name
    Qantev SAS
    Investment activity status
    Active investor

    Company type

    Health insurance claims platform.

    Overview

    QantEv helps health insurers negotiate and select the best healthcare provider network for theirmembers. Its enterprise software solution has received great attention from leading insurersacross the world to transform their health insurance operations. QantEv is backed by $1.7m inventure capital and is based in Paris, France.

    Funding rounds

    Series B EUR 30,000,000


    (9 Oct 2024) Change in valuation: unknown

    Profile Country Notes
    Blossom Capital Initial investment. Led the round.
    Elaia Partners SAS European venture capital firm focused on digital & deep tech startups, from early stage to growth development. France Follow-on investment. Round participant.
    Omnes Capital France Follow-on investment. Round participant.
    Raise Conseil SAS France Follow-on investment. Round participant.

    Series A EUR 10,000,000


    (2022) Change in valuation: unknown

    Profile Country Notes
    Omnes Capital France Initial investment. Led the round.
    Raise Conseil SAS France Initial investment. Led the round.

    Seed EUR 1,700,000


    (2020) Change in valuation: unknown

    Profile Country Notes
    Elaia Partners SAS European venture capital firm focused on digital & deep tech startups, from early stage to growth development. France Initial investment. Led the round.

    Current and past shareholders

    Investor Contacts Round
    Blossom Capital logo Blossom Capital
    Series B
    Elaia Partners logo Elaia Partners SAS
    European venture capital firm focused on digital & deep tech startups, from early stage to growth development.
    +33 (1) 7674-9250
    Seed
    Series B
    Omnes Capital logo Omnes Capital
    Series A
    Series B
    Raise Ventures logo Raise Conseil SAS
    Series A
    Series B